Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Daiichi Sankyo
QuintilesIMS
Covington
Deloitte
Citi
Chinese Patent Office
Mallinckrodt
Accenture
Healthtrust

Generated: February 21, 2018

DrugPatentWatch Database Preview

CLONAZEPAM - Generic Drug Details

« Back to Dashboard

What are the generic sources for clonazepam and what is the scope of clonazepam freedom to operate?

Clonazepam
is the generic ingredient in three branded drugs marketed by Barr, Par Pharm, Sun Pharm Inds Inc, Roche, Accord Hlthcare, Actavis Elizabeth, Apotex Inc, Mylan, Mylan Pharms Inc, Prinston Inc, Sandoz, Teva, and Watson Labs, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for clonazepam. Forty-nine suppliers are listed for this compound.
Pharmacology for CLONAZEPAM
Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for CLONAZEPAM

US Patents and Regulatory Information for CLONAZEPAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche KLONOPIN clonazepam TABLET;ORAL 017533-006 Apr 9, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz CLONAZEPAM clonazepam TABLET;ORAL 074925-002 Sep 30, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz CLONAZEPAM clonazepam TABLET;ORAL 074979-003 Aug 29, 1997 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz CLONAZEPAM clonazepam TABLET;ORAL 074925-001 Sep 30, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-003 Dec 23, 1997 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc CLONAZEPAM clonazepam TABLET;ORAL 074940-001 Oct 30, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex Inc CLONAZEPAM clonazepam TABLET;ORAL 075468-001 Oct 6, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva CLONAZEPAM clonazepam TABLET;ORAL 074569-003 Sep 10, 1996 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz CLONAZEPAM clonazepam TABLET;ORAL 074979-001 Aug 29, 1997 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Prinston Inc CLONAZEPAM clonazepam TABLET;ORAL 077856-002 Jun 28, 2006 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CLONAZEPAM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-005 Dec 23, 1997 ➤ Sign Up ➤ Sign Up
Roche KLONOPIN clonazepam TABLET;ORAL 017533-003 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-001 Dec 23, 1997 ➤ Sign Up ➤ Sign Up
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-002 Dec 23, 1997 ➤ Sign Up ➤ Sign Up
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-003 Dec 23, 1997 ➤ Sign Up ➤ Sign Up
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-005 Dec 23, 1997 ➤ Sign Up ➤ Sign Up
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-002 Dec 23, 1997 ➤ Sign Up ➤ Sign Up
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-003 Dec 23, 1997 ➤ Sign Up ➤ Sign Up
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-004 Dec 23, 1997 ➤ Sign Up ➤ Sign Up
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-003 Dec 23, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
US Department of Justice
AstraZeneca
Colorcon
Healthtrust
Mallinckrodt
Farmers Insurance
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot